In these conditions of supply the following words will (unless the context otherwise requires) have the following meanings:
"Healthcare Customer Services Contact" means our customer services representatives on Tel: +44 (0)115 9739015.
"Conditions" the conditions set out below and overleaf.
"Contract" the contract between us and you for the supply of Services comprising these Conditions and any documents referred to in them.
"Data Protection Legislation" the Data Protection Act 1998 and all subordinate legislation;
"FFPE Block" means a formalin fixed paraffin embedded block;
"Favourable Test Outcome" means either of the following outcomes of the Mutation Analysis undertaken by us:
- Activating mutation detected for the specific gene being analysed (KRAS, BRAF, NRAS, EGFR or PIK3CA as applicable to your Order);
- No activating mutation detected for the specific gene being analysed (KRAS, BRAF, NRAS, EGFR or PIK3CA as applicable to your Order).
"Laboratory" Source BioScience UK Limited's laboratory at 1 Orchard Place, Nottingham Business Park, Nottingham NG8 6PX;
"Mutation Analysis" the laboratory testing for the purpose of the identification of specific activating mutations in a specific gene, including but not limited to, KRAS, BRAF, NRAS, EGFR and PIK3CA;
"Orders" as defined in term 4.1;
"Party" you or Source BioScience UK Limited ; "Parties" means you and Source BioScience UK Limited;
"Personal Data" any data compiled and/or processed by Source BioScience UK Limited pursuant to this Contract which identifies a living individual;
"Products" the extracted genomic DNA that is generated by Source BioScience UK Limited in preparing a Sample for Services;
"Results" means the narrative report and/or any data arising out of the results of the Services including the outcome of the Mutation Analysis undertaken by us which may be, Favourable Test Outcome or Unfavourable Test Outcome, as defined herein;
"Samples" the specimens supplied by you to us for use in respect of the Services;
"Services" means the services to be performed by us which includeMutation Analysis and involves a histopathology review of a specimen to ensure tumour tissue is present, analysis of data and the communication of all results related to Mutation Analysis to the referring clinician;
"Unfavourable Test Outcome" means the following outcome of the Mutation Analysis undertaken by us:
- No Result for this specimen.
"we" / "us" / "our" Source BioScience UK Limited, a company registered in England and Wales with number 4078501 and whose registered office is 1 Orchard Place, Nottingham Business Park, Nottingham NG8 6PX.
"you" / "your" the company, academic institution, firm, body or any representative thereof or any other person who orders the Services.